Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
Suspended
  • Leukemia
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2021-12-29
Dec 29, 2021
N
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy, Including Boost...
Recruiting
  • Solid Tumor Malignancy
  • +4 more
  • mRNA-1273
  • Bethesda, Maryland
  • +1 more
2022-01-13
Jan 13, 2022
I
National Longitudinal Cohort of Hematological Diseases
Recruiting
  • Multiple Myeloma
  • +17 more
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    2022-01-11
    Jan 11, 2022
    B
    Decitabine, Cytarabine, GCSF for Refractory AML/MDS - 2010
    Terminated
    Has Results
    • Myelodysplasia
    • Leukemia
    • Providence, Rhode Island
      Lifespan Hospitals
    2022-01-05
    Jan 5, 2022
    A
    Early Integration of Palliative and Supportive Care in Hematopoietic Stem Cell Transplantation
    Not yet recruiting
    • Leukemia
    • +4 more
    • Early palliative and supportive care
    • Calgary, Alberta, Canada
      Tom Baker Cancer Centre
    2021-12-29
    Dec 29, 2021
    M
    Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
    Active, not recruiting
    • Leukemia
    • KIR genotyping
    • HLA genotyping
    • Tampa, Florida
    • +9 more
    2022-01-12
    Jan 12, 2022
    N
    Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
    Recruiting
    • Leukemia
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-01-11
      Jan 11, 2022
      N
      Case-Control Study of Pesticides and Childhood Leukemia
      Completed
      • Leukemia
        • Berkeley, California
          University of California, Berkeley
        2022-01-11
        Jan 11, 2022
        N
        Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
        Completed
        • Multiple Myeloma
        • +3 more
          • Iowa City, Iowa
          • +1 more
          2022-01-11
          Jan 11, 2022
          B
          A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies - 2021
          Terminated
          • Leukemia
          • Bronx, New York
          • +4 more
          2021-12-20
          Dec 20, 2021
          P
          Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
          Not yet recruiting
          • Lymphoma
          • +6 more
          • Digital Health Coaching
          • Houston, Texas
            The University of Texas MD Anderson Cancer Center
          2022-01-05
          Jan 5, 2022
          F
          Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
          Not yet recruiting
          • Clinical Stage I Cutaneous Melanoma AJCC v8
          • +33 more
          • Informational Intervention
          • +4 more
          • Los Angeles, California
          • +4 more
          2022-01-04
          Jan 4, 2022
          M
          Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
          Recruiting
          • Breast Cancer
          • +2 more
          • Cardiac Imaging
          • Data Collection
          • Montréal, Quebec, Canada
          • +1 more
          2021-12-15
          Dec 15, 2021
          P
          A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
          Recruiting
          • Leukemia
          • +2 more
          • inotuzumab ozogamicin-dose level 2
          • Inotuzumab ozogamicin-dose level 1
          • Los Angeles, California
          • +49 more
          2022-01-04
          Jan 4, 2022
          U
          Early Ageing During Therapy in AYA Cancer Patients
          Not yet recruiting
          • Cancer
          • +7 more
          • Blood sampling
          • Groningen, Netherlands
            University Medical Center Groningen
          2022-01-04
          Jan 4, 2022
          T
          Tempus Priority Study: A Pan-tumor Observational Study
          Recruiting
          • Breast Cancer
          • +26 more
            • Covington, Louisiana
            • +4 more
            2021-12-16
            Dec 16, 2021
            N
            Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia - 2021
            Completed
            • Leukemia
            • +3 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            2021-12-31
            Dec 31, 2021
            N
            Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
            Recruiting
            • Glioblastomas
            • +4 more
            • Enhanced Mindfulness Intervention
            • Psychoeducation
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            2021-12-31
            Dec 31, 2021
            G
            Phase III Trial in Acute Promyelocytic Leukemia Patients
            Active, not recruiting
            • Leukemia
            • arsenic trioxide
            • +5 more
            • Innsbruck, Austria
            • +109 more
            2021-12-31
            Dec 31, 2021
            G
            Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia - 2014
            Completed
            • Leukemia
            • imatinib mesylate
            • +8 more
            • Rionero in Vulture, Potenza, Italy
            • +36 more
            2022-01-03
            Jan 3, 2022
            M
            A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
            Recruiting
            • Lymphoma
            • Leukemia
            • Duarte, California
            • +9 more
            2021-12-28
            Dec 28, 2021
            C
            A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
            Recruiting
            • Leukemia
            • Myelodysplastic Syndrome(MDS)
            • Duarte, California
              City of Hope
            2021-12-09
            Dec 9, 2021
            V
            Allogeneic Stem Cell Transplantationin Relapsed Hematological Malignancy: Early GVHD Prophylaxis
            Active, not recruiting
            • Hodgkin's Lymphoma
            • +17 more
            • mycophenolate mofetil
            • +2 more
            • Richmond, Virginia
              Virginia Commonwealth University/Massey Cancer Center
            2021-12-21
            Dec 21, 2021
            S
            Medical Treatment Decision Making Using Adaptive Conjoint Analysis - 2019
            Terminated
            • Cancer
            • +4 more
              • Memphis, Tennessee
                St. Jude Children's Research Hospital
              2021-12-20
              Dec 20, 2021
              G
              90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia
              Not yet recruiting
              • Leukemia
              • 90-Yttrium-labelled anti-CD66 monoclonal antibody
              • (no location specified)
              2021-12-15
              Dec 15, 2021